Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model

scientific article published on January 1985

Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/BJC.1985.15
P932PMC publication ID1976814
P698PubMed publication ID3966964
P5875ResearchGate publication ID19194906

P2093author name stringHowatson AG
Carter DC
P2860cites workA study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidQ26778512
A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amineQ28331427
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practicesQ33951666
Islet cells as a component of pancreatic ductal neoplasms. I. Experimental study: ductular cells, including islet cell precursors, as primary progenitor cells of tumorsQ36058406
Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lectureQ39991517
Recent developments in the measurement of nucleic acids in biological materials. A supplementary reviewQ40031065
Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of ratsQ40864402
Methylated purines in the deoxyribonucleic acid of various Syrian-golden-hamster tissues after administration of a hepatocarcinogenic dose of dimethylnitrosamineQ42535582
An epidemiological evaluation of the causes of cancer of the pancreasQ50155960
N'-nitrosonornicotine in tobacco.Q54263979
Possible Synthesis of Polyribonucleotides of Known Base-triplet SequencesQ58970965
Cancer mortality among chemistsQ64916803
The properties of O 6 -methylguanine in templates for RNA polymeraseQ69521209
Chemical carcinogenesisQ69955579
Activation of nitrosamines to mutagens by postmitochondrial fraction of hamster pancreasQ71127549
Electron microscopic autoradiography of the pancreas in the hamster treated with tritiated N-nitroso-2,6-dimethylmorpholineQ72139488
Cohort study of workers exposed to betanaphthylamine and benzidineQ72223303
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectcarcinogenesisQ1637543
cholecystokininQ60315441
P304page(s)107-114
P577publication date1985-01-01
P1433published inBritish Journal of CancerQ326309
P1476titlePancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model
P478volume51

Reverse relations

cites work (P2860)
Q34343379A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States).
Q37975722Aetiology of pancreatic cancer
Q44946442Are energy and energy-providing nutrients related to exocrine carcinoma of the pancreas?
Q43607852Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands
Q34533173Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor
Q41614766Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin
Q41859754Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer
Q34394264Biology of pancreatic cancer
Q41694806CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium
Q68516308Cancer of the pancreas
Q81349587Carcinoid syndrome misdiagnosed as a malabsorptive syndrome after biliopancreatic diversion
Q37370473Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma
Q33816883Cholecystokinin and pancreatic cancer: the chicken or the egg?
Q36071597Cholecystokinin antagonists--a toxicologic perspective
Q33894658Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.
Q50085980Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice
Q34167464Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice
Q41207409Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines
Q68581002Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990
Q78158063Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer
Q41525783Comparative effects of neurotensin and neuromedin N on growth of human pancreatic cancer, MIA PaCa-2.
Q36620579Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
Q37352570Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands
Q72969104Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters
Q34533241Effect of experimental pancreatic growth on the content of xenobiotic-metabolising enzymes in the pancreas
Q41731843Effects of a high-fat diet and L364,718 on growth of human pancreas cancer
Q77619819Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat
Q41660160Effects of cholecystokinin on cytosolic calcium in human pancreatic cancer cells
Q53447303Effects of high-fat diet and cholecystokinin receptor blockade on promotion of pancreatic ductal cell tumors in the hamster.
Q44067981Effects of long term feeding of raw soya bean flour on virus-induced pancreatic carcinogenesis in guinea fowl
Q70879336Enhancement of biliary carcinogenesis in hamsters by cholecystokinin
Q39744559Food and cancer: cause and effect?
Q77750257Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma
Q40712629Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.
Q43721752Increased incidence of pancreatic neoplasia in pernicious anemia
Q39255670Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents
Q68325503Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide
Q41827161Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion
Q39685995Interface between adaptive and neoplastic growth in the pancreas
Q38041420Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents
Q53479476Kinetic changes and experimental carcinogenesis after Billroth I and II gastrectomy.
Q56780047Life-time history of smoking and exocrine carcinoma of the pancreas: A population-based case-control study in the Netherlands
Q41936517Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice
Q40452708On the role of cholecystokinin in pancreatic cancer.
Q35631058PPARalpha agonist-induced rodent tumors: modes of action and human relevance
Q35613016Pancreatic cancer - a continuing challenge in oncology
Q53440833Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia.
Q28372029Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers
Q35645684Pancreatic cancer: the role of cholecystokinin?
Q34604661Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines
Q33841242Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin
Q41154883Proliferative response of different exocrine pancreatic cells after surgical pancreaticobiliary diversion in the rat.
Q69370107Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement
Q43514547Risk factors for pancreatic cancer: a case-control study based on direct interviews
Q35365557Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden
Q35564914Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues
Q35994163Somatostatin binding in normal and malignant human gastrointestinal mucosa
Q44213678Structural changes of the exocrine pancreas in a patient with cholecystolithiasis
Q36852664The activation of beta-substituted nitrosamines that are carcinogenic to the pancreas.
Q40548301The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth
Q57704454Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma

Search more.